Blunted serum erythropoietin response to anemia in patients polytransfused for β-thalassemia major

Jiann Shiuh Chen, Kai Hsin Lin, Shan Tair Wang, Chao Jung Tsao, Tsu Fuh Yeh

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Purpose: To investigate the response of erythropoietin (EPO) to anemia in patients polytransfused for β-thalassemia major. Patients and Methods: We measured the serum EPO levels and the concurrent hemoglobin (Hb) concentrations in 40 patients polytransfused for β-thalassemia major, in 18 patients with iron deficiency anemia (IDA), and 32 healthy subjects. Serum EPO levels were assayed by an enzyme immunoassay. Results: In both groups with β-thalassemia major and IDA, serum EPO levels were significantly elevated (114 ± 71 and 239 ± 217 mU/mL, respectively). There was a significant inverse correlation between log EPO values and Hb concentrations in patients with β-thalassemia major (r = 0.61; p <0.01) and IDA (r = 0.81; p <0.01). In a semilogarithmic plot, the slope of the regression line obtained in patients with β-thalassemia major was significantly lower than that of IDA (p <0.01), suggesting a blunted EPO response to anemia in patients polytransfused for β-thalassemia major. The elevation of serum EPO in patients with β-thalassemia major was poorly related to clinical variables except serum ferritin. Conclusions: We conclude that a significant inverse relationship between serum EPO levels and Hb concentration exists in patients with β-thalassemia major. However, this EPO response in patients with anemia caused by β-thalassemia major may be blunted when compared to patients with IDA.

Original languageEnglish
Pages (from-to)140-144
Number of pages5
JournalJournal of Pediatric Hematology/Oncology
Volume20
Issue number2
DOIs
Publication statusPublished - Mar 1 1998
Externally publishedYes

Fingerprint

beta-Thalassemia
Erythropoietin
Anemia
Iron-Deficiency Anemias
Serum
Hemoglobins
Ferritins
Immunoenzyme Techniques
Healthy Volunteers

Keywords

  • β-thalassemia major
  • Erythropoietin

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Hematology
  • Oncology

Cite this

Blunted serum erythropoietin response to anemia in patients polytransfused for β-thalassemia major. / Chen, Jiann Shiuh; Lin, Kai Hsin; Wang, Shan Tair; Tsao, Chao Jung; Yeh, Tsu Fuh.

In: Journal of Pediatric Hematology/Oncology, Vol. 20, No. 2, 01.03.1998, p. 140-144.

Research output: Contribution to journalArticle

Chen, Jiann Shiuh ; Lin, Kai Hsin ; Wang, Shan Tair ; Tsao, Chao Jung ; Yeh, Tsu Fuh. / Blunted serum erythropoietin response to anemia in patients polytransfused for β-thalassemia major. In: Journal of Pediatric Hematology/Oncology. 1998 ; Vol. 20, No. 2. pp. 140-144.
@article{31f38c3aa28a4f52a4429cbbc8b96830,
title = "Blunted serum erythropoietin response to anemia in patients polytransfused for β-thalassemia major",
abstract = "Purpose: To investigate the response of erythropoietin (EPO) to anemia in patients polytransfused for β-thalassemia major. Patients and Methods: We measured the serum EPO levels and the concurrent hemoglobin (Hb) concentrations in 40 patients polytransfused for β-thalassemia major, in 18 patients with iron deficiency anemia (IDA), and 32 healthy subjects. Serum EPO levels were assayed by an enzyme immunoassay. Results: In both groups with β-thalassemia major and IDA, serum EPO levels were significantly elevated (114 ± 71 and 239 ± 217 mU/mL, respectively). There was a significant inverse correlation between log EPO values and Hb concentrations in patients with β-thalassemia major (r = 0.61; p <0.01) and IDA (r = 0.81; p <0.01). In a semilogarithmic plot, the slope of the regression line obtained in patients with β-thalassemia major was significantly lower than that of IDA (p <0.01), suggesting a blunted EPO response to anemia in patients polytransfused for β-thalassemia major. The elevation of serum EPO in patients with β-thalassemia major was poorly related to clinical variables except serum ferritin. Conclusions: We conclude that a significant inverse relationship between serum EPO levels and Hb concentration exists in patients with β-thalassemia major. However, this EPO response in patients with anemia caused by β-thalassemia major may be blunted when compared to patients with IDA.",
keywords = "β-thalassemia major, Erythropoietin",
author = "Chen, {Jiann Shiuh} and Lin, {Kai Hsin} and Wang, {Shan Tair} and Tsao, {Chao Jung} and Yeh, {Tsu Fuh}",
year = "1998",
month = "3",
day = "1",
doi = "10.1097/00043426-199803000-00010",
language = "English",
volume = "20",
pages = "140--144",
journal = "Journal of Pediatric Hematology/Oncology",
issn = "1077-4114",
publisher = "Lippincott Williams and Wilkins",
number = "2",

}

TY - JOUR

T1 - Blunted serum erythropoietin response to anemia in patients polytransfused for β-thalassemia major

AU - Chen, Jiann Shiuh

AU - Lin, Kai Hsin

AU - Wang, Shan Tair

AU - Tsao, Chao Jung

AU - Yeh, Tsu Fuh

PY - 1998/3/1

Y1 - 1998/3/1

N2 - Purpose: To investigate the response of erythropoietin (EPO) to anemia in patients polytransfused for β-thalassemia major. Patients and Methods: We measured the serum EPO levels and the concurrent hemoglobin (Hb) concentrations in 40 patients polytransfused for β-thalassemia major, in 18 patients with iron deficiency anemia (IDA), and 32 healthy subjects. Serum EPO levels were assayed by an enzyme immunoassay. Results: In both groups with β-thalassemia major and IDA, serum EPO levels were significantly elevated (114 ± 71 and 239 ± 217 mU/mL, respectively). There was a significant inverse correlation between log EPO values and Hb concentrations in patients with β-thalassemia major (r = 0.61; p <0.01) and IDA (r = 0.81; p <0.01). In a semilogarithmic plot, the slope of the regression line obtained in patients with β-thalassemia major was significantly lower than that of IDA (p <0.01), suggesting a blunted EPO response to anemia in patients polytransfused for β-thalassemia major. The elevation of serum EPO in patients with β-thalassemia major was poorly related to clinical variables except serum ferritin. Conclusions: We conclude that a significant inverse relationship between serum EPO levels and Hb concentration exists in patients with β-thalassemia major. However, this EPO response in patients with anemia caused by β-thalassemia major may be blunted when compared to patients with IDA.

AB - Purpose: To investigate the response of erythropoietin (EPO) to anemia in patients polytransfused for β-thalassemia major. Patients and Methods: We measured the serum EPO levels and the concurrent hemoglobin (Hb) concentrations in 40 patients polytransfused for β-thalassemia major, in 18 patients with iron deficiency anemia (IDA), and 32 healthy subjects. Serum EPO levels were assayed by an enzyme immunoassay. Results: In both groups with β-thalassemia major and IDA, serum EPO levels were significantly elevated (114 ± 71 and 239 ± 217 mU/mL, respectively). There was a significant inverse correlation between log EPO values and Hb concentrations in patients with β-thalassemia major (r = 0.61; p <0.01) and IDA (r = 0.81; p <0.01). In a semilogarithmic plot, the slope of the regression line obtained in patients with β-thalassemia major was significantly lower than that of IDA (p <0.01), suggesting a blunted EPO response to anemia in patients polytransfused for β-thalassemia major. The elevation of serum EPO in patients with β-thalassemia major was poorly related to clinical variables except serum ferritin. Conclusions: We conclude that a significant inverse relationship between serum EPO levels and Hb concentration exists in patients with β-thalassemia major. However, this EPO response in patients with anemia caused by β-thalassemia major may be blunted when compared to patients with IDA.

KW - β-thalassemia major

KW - Erythropoietin

UR - http://www.scopus.com/inward/record.url?scp=0031924652&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031924652&partnerID=8YFLogxK

U2 - 10.1097/00043426-199803000-00010

DO - 10.1097/00043426-199803000-00010

M3 - Article

C2 - 9544165

AN - SCOPUS:0031924652

VL - 20

SP - 140

EP - 144

JO - Journal of Pediatric Hematology/Oncology

JF - Journal of Pediatric Hematology/Oncology

SN - 1077-4114

IS - 2

ER -